Proem Behavioral Health CEO John Letter recently appeared on the "Tech Talks Daily Podcast" to discuss how technology, including the Proem platform, is reshaping the global mental health landscape.
Dual diagnosis treatment is among the most demanding challenges facing substance use disorder (SUD) clinics. Data suggests that more than 15% of individuals with SUD also have a serious mental illness (SMI) and nearly 30% of individuals with SMI also have SUD, yet only 10% of...
A carefully planned substance use disorder (SUD) assessment is essential to the treatment process. Unless the clinical team understands how addiction affects the patient and whether any other co-occurring disorders are at play, developing an effective treatment plan is...
The Centers for Medicare & Medicaid Services (CMS) recently issued the 2024 Medicare Physician Fee Schedule (PFS) final rule, and it includes significant developments that will benefit individuals with mental illness and the behavioral health industry as a whole.
Men's Health Awareness Month in November provides a unique opportunity to explore the intricate connection between mental and physical well-being. This month serves as a reminder of the complex interplay between these two aspects and the critical need for early intervention and...
In a recent episode of the MGMA Mindful Medicine podcast, Dr. Thomas Young, Chief Medical Officer at Proem Behavioral Health, engaged in a thought-provoking discussion with Daniel Williams, Senior Editor at MGMA and host of the MGMA podcast network.
Anxiety and substance use disorder (SUD) are among the most common psychiatric diagnoses in the United States, with a respective lifetime prevalence of 28.8% and 14.6%. Psychiatric Times has noted that in any 12 months, 33% to 45% of individuals with anxiety disorder will ...
NeuroBehavioral Hospitals Selects Proem Behavioral Health to Support Patient Care and Engagement
Software company provides Florida-based mental health treatment services provider with comprehensive platform and data analytics to support measurement-based care.
ATLANTA, October...
The most recent National Survey of Drug Use and Health showed that approximately 18 million adults aged 18 or older in 2021 had a co-occurring mental illness and illicit drug or alcohol use disorder in the prior year.
According to the National Institute on Drug Abuse (NIDA), approximately half of people with a mental illness will develop a co-occurring substance use disorder (SUD) in their lifetimes and vice versa. One of the most common co-occurring combinations is depression and substance...




